The global demand for Subdermal Contraceptive Implants Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.
Subdermal contraceptive implants imply delivery of a steroid progestin from polymer capsules or rods surgically implanted into the upper non-dominant arm. Typically, the protection span is 1-5 years, however, it varies based on the type of progestin and polymer used. Once the implant is inserted, it allows a woman to have coitus for certain time without any substantial risk of getting pregnant. The implants are of a size of matchstick and works by constraining ovulation. The progestin thickens the cervical mucus, which then restricts the passage of sperm to the uterus. The progestin is responsible for thinning the endometrium which then inhibits implantation.
With more people embracing modern and safe contraceptive methods, an increase in disposable income and population control advisory issued by the government is steering the growth of the worldwide subdermal contraceptive implant market. However, issues like psychological side-effects, chances of failure and a well-established market of contraceptive pills are expected to hamper the market growth. The subdermal contraceptive implants are expected to witness huge demands owing to its efficacy, longer span of contraception, and easy insertion and removal procedure. Other factors driving the global revenues of the subdermal contraceptive market are the rising number of working women, unplanned pregnancies and rising concern regarding sexual health.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of subdermal contraceptive implants.
The entire subdermal contraceptive implants market has been sub-categorized into type and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
- Etonogestrel Implant
- Levonorgestrel Implant
This section covers regional segmentation which accentuates on current and future demand for subdermal contraceptive implants market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Subdermal Contraceptive Implants Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the subdermal contraceptive implants market include Bayer AG, Merck & Co. Inc., Shanghai Dahua Pharmaceutical Co., Ltd., Others. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers& acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.